D

동성제약

002210KOSPI의약품 제조업

37.3 / 100

Reference Date: 2026-07-24

Financial Score4.5 / 40
News Sentiment15.8 / 25
Momentum10.0 / 20
Disclosure7.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Roughly flat over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Dongseong Pharmaceutical operates 13 facilities across South Korea, with headquarters in Seoul, and is divided into three business segments: pharmaceuticals, hair dyes, and cosmetics. Key products include Jeongrohwan, Seven Eight, and Lances, with pharmaceuticals and hair dyes produced in-house at the Asan plant, while cosmetics are sold through purchased goods.

Number of Employees

307people

Average Salary

42.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 11.234.0Point
PBR
4.02Industry Average 0.810.0Point

5.0x industry avg (risky)

ROE
-76.44Industry Average 4.010.0Point

Well below industry avg

Debt Ratio
65.78Industry Average 12.430.0Point

5.3x industry avg (risky)

Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼0.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼629.5% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -32.2% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 1Neutral 1Negative 1Average Sentiment Score 63.3

Detailed Momentum

52-week position4.0Point

52w mid range (50%)

Current 973Won52-week high 97352-week low 973
1-month return3.0Point

1m 0% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

2 totalPositive 0Neutral 1Negative 1
  • Neutral기타시장안내 (상장적격성 실질심사 사유 추가 관련 안내)2026-07-15
  • Negative불성실공시법인지정2026-07-15